Amalgamated Bank’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.09M | Buy |
9,468
+615
| +7% | +$201K | 0.02% | 606 |
|
|
2025
Q1 | $2.39M | Buy |
8,853
+369
| +4% | +$99.6K | 0.02% | 701 |
|
|
2024
Q4 | $2M | Buy |
8,484
+205
| +2% | +$48.2K | 0.02% | 801 |
|
|
2024
Q3 | $2.28M | Sell |
8,279
-75
| -0.9% | -$20.6K | 0.02% | 760 |
|
|
2024
Q2 | $2.03M | Buy |
8,354
+301
| +4% | +$73.1K | 0.02% | 833 |
|
|
2024
Q1 | $1.2M | Sell |
8,053
-3,306
| -29% | -$494K | 0.01% | 996 |
|
|
2023
Q4 | $2.17M | Sell |
11,359
-1,387
| -11% | -$265K | 0.02% | 877 |
|
|
2023
Q3 | $2.26M | Sell |
12,746
-400
| -3% | -$70.8K | 0.02% | 831 |
|
|
2023
Q2 | $2.5M | Sell |
13,146
-932
| -7% | -$177K | 0.02% | 794 |
|
|
2023
Q1 | $2.82M | Buy |
14,078
+211
| +2% | +$42.3K | 0.02% | 732 |
|
|
2022
Q4 | $3.3M | Buy |
13,867
+387
| +3% | +$92K | 0.03% | 700 |
|
|
2022
Q3 | $2.7M | Buy |
13,480
+213
| +2% | +$42.6K | 0.03% | 698 |
|
|
2022
Q2 | $1.94M | Sell |
13,267
-88
| -0.7% | -$12.8K | 0.02% | 880 |
|
|
2022
Q1 | $2.18M | Buy |
13,355
+2,877
| +27% | +$470K | 0.02% | 888 |
|
|
2021
Q4 | $1.78M | Buy |
10,478
+3,602
| +52% | +$611K | 0.01% | 998 |
|
|
2021
Q3 | $1.3M | Sell |
6,876
-1,068
| -13% | -$202K | 0.01% | 1125 |
|
|
2021
Q2 | $1.35M | Buy |
7,944
+2,264
| +40% | +$384K | 0.01% | 1140 |
|
|
2021
Q1 | $802K | Sell |
5,680
-338
| -6% | -$47.7K | 0.03% | 704 |
|
|
2020
Q4 | $782K | Sell |
6,018
-88
| -1% | -$11.4K | 0.03% | 700 |
|
|
2020
Q3 | $889K | Sell |
6,106
-43
| -0.7% | -$6.26K | 0.04% | 506 |
|
|
2020
Q2 | $911K | Sell |
6,149
-20,994
| -77% | -$3.11M | 0.04% | 459 |
|
|
2020
Q1 | $2.96M | Sell |
27,143
-331
| -1% | -$36K | 0.07% | 241 |
|
|
2019
Q4 | $3.16M | Buy |
27,474
+1,506
| +6% | +$173K | 0.06% | 312 |
|
|
2019
Q3 | $2.09M | Buy |
25,968
+2,888
| +13% | +$232K | 0.04% | 420 |
|
|
2019
Q2 | $1.68M | Buy |
23,080
+2,109
| +10% | +$153K | 0.04% | 496 |
|
|
2019
Q1 | $1.96M | Buy |
20,971
+1,401
| +7% | +$131K | 0.05% | 393 |
|
|
2018
Q4 | $1.43M | Buy |
19,570
+6,795
| +53% | +$495K | 0.04% | 472 |
|
|
2018
Q3 | $1.12M | Sell |
12,775
-7,645
| -37% | -$669K | 0.03% | 626 |
|
|
2018
Q2 | $2.01M | Buy |
20,420
+2,080
| +11% | +$205K | 0.05% | 383 |
|
|
2018
Q1 | $2.18M | Buy |
18,340
+1,228
| +7% | +$146K | 0.06% | 335 |
|
|
2017
Q4 | $2.17M | Buy |
17,112
+2,070
| +14% | +$263K | 0.06% | 319 |
|
|
2017
Q3 | $1.77M | Buy |
15,042
+1,084
| +8% | +$127K | 0.06% | 346 |
|
|
2017
Q2 | $1.11M | Buy |
13,958
+3,052
| +28% | +$243K | 0.04% | 585 |
|
|
2017
Q1 | $559K | Sell |
10,906
-2,055
| -16% | -$105K | 0.03% | 769 |
|
|
2016
Q4 | $485K | Buy |
12,961
+1,392
| +12% | +$52.1K | 0.02% | 854 |
|
|
2016
Q3 | $784K | Buy |
11,569
+4
| +0% | +$271 | 0.05% | 486 |
|
|
2016
Q2 | $859K | Buy |
+11,565
| New | +$859K | 0.05% | 443 |
|
|
2015
Q3 | – | Sell |
-2,224
| Closed | -$267K | – | 1311 |
|
|
2015
Q2 | $267K | Sell |
2,224
-4,968
| -69% | -$596K | 0.03% | 1057 |
|
|
2015
Q1 | $751K | Buy |
7,192
+818
| +13% | +$85.4K | 0.09% | 265 |
|
|
2014
Q4 | $618K | Buy |
6,374
+17
| +0.3% | +$1.65K | 0.1% | 262 |
|
|
2014
Q3 | $496K | Buy |
6,357
+79
| +1% | +$6.16K | 0.07% | 350 |
|
|
2014
Q2 | $397K | Buy |
6,278
+601
| +11% | +$38K | 0.06% | 461 |
|
|
2014
Q1 | $381K | Sell |
5,677
-51
| -0.9% | -$3.42K | 0.07% | 438 |
|
|
2013
Q4 | $368K | Buy |
+5,728
| New | +$368K | 0.06% | 459 |
|